SNS Research
Menu
Your Markets, Our Intelligence
SNS Research is an independent market intelligence and consulting company with expertise in the healthcare & pharmaceutical sector. Our team of analysts are experienced in identifying key market insights and providing objective analysis. Our syndicated research reports, forecasting datasets, and clinical drug pipelines are designed for organizations looking to gain an edge in their respective markets. Take your corporate strategy and decision-making to the next level with the help of our strategic foresight. 

Healthcare & Pharma Reports
mobile health report
Drug Development Pipelines

Leading Research

The mHealth (Mobile Healthcare) Ecosystem 2022
The Generic Drugs Market
The Dermatological Drugs Market
The Glaucoma Drugs Market
The Ophthalmic Drugs Market
The Biosimilar Drugs Market
The Retinal Disorder Drugs Market
The Psoriasis Drugs Market
Big Data in the Healthcare & Pharmaceutical Industry

    Subscribe for Latest Updates

Submit

Search Website



Notable Customers


Media Coverage

​What Our Customers Say About Us

Valeant Pharmaceuticals refers forecasts from our Glaucoma Drugs Report (Page 7)

Outlook Therapeutics features our Biosimilars Report in their IPO document (Page77-79)
​
Drug Development references findings from our Prefilled Syringes Market Report (Page 31)

Optometery Today by Association of Optometrists refers to our Ophthalmic Drugs Market Report

Air Cargo Eye refers to our Dermatological Drugs Market Report

​
Clarkson Consulting refers to our mHealth Forecasts in the Life Sciences Trends Report


Outsiders Club refers to our Generic Drugs research

The SNS report covering “The Dermatological Drugs Market” is an invaluable one stop resource for plethora of information regarding the dermatological market. This report provides comprehensive view to both the business aspect as well as to the clinical one of the Derma market. It constitutes both an introduction to the various indications targeted at all that may want to enter into this vastly growing market, as well as to the commercial aspect of it, offering an encompassing analysis of the main players, the economics. Moreover, with its 15 years vision, it provides thoughtful projections into the future.
Nadav Schreibom, CEO, Sirbal LTD.

Our Research & Services

​Pharma Research Library
​Clinical Pipeline Datasets
Request Clinical Pipeline Data
Send an Inquiry
Purchase Report

Company

Home
​Our Customers
​​About Us 
​Media Coverage

More

Subscribe for Latest Updates
​Privacy Policy
​Disclosures
​
​​Contact Us

​​​Email Us:
info@snsintel.com

​© SNS Research Group LLC COPYRIGHT 2022. ALL RIGHTS RESERVED.
  • Pharma Reports
  • Drug Pipeline Data
  • Our Customers
  • Media Coverage
  • About Us
  • Contact Us
  • Subscribe
  • Pharma Reports
  • Drug Pipeline Data
  • Our Customers
  • Media Coverage
  • About Us
  • Contact Us
  • Subscribe